File size: 81,370 Bytes
24b4116 |
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866 867 868 869 870 871 872 873 874 875 876 877 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 |
---
library_name: sentence-transformers
pipeline_tag: sentence-similarity
tags:
- sentence-transformers
- sentence-similarity
- feature-extraction
- generated_from_trainer
- dataset_size:26147930
- loss:MultipleNegativesRankingLoss
widget:
- source_sentence: '[YEAR_RANGE] 2020-2024 [TEXT] Vitamin B-6 Prevents Heart Failure
with Preserved Ejection Fraction Through Downstream of Kinase 3 in a Mouse Model.'
sentences:
- '[YEAR_RANGE] 2020-2024 [TEXT] Colorectal cancer (CRC) is a complex and genetically
heterogeneous disease presenting a specific metastatic pattern, with the liver
being the most common site of metastasis. Around 20%-25% of patients with CRC
will develop exclusively hepatic metastatic disease throughout their disease history.
With its specific characteristics and therapeutic options, liver-limited disease
(LLD) should be considered as a specific entity. The identification of these patients
is particularly relevant in view of the growing interest in liver transplantation
in selected patients with advanced CRC. Identifying why some patients will develop
only LLD remains a challenge, mainly because of a lack of a systemic understanding
of this complex and interlinked phenomenon given that cancer has traditionally
been investigated according to distinct physiological compartments. Recently,
multidisciplinary efforts and new diagnostic tools have made it possible to study
some of these complex issues in greater depth and may help identify targets and
specific treatment strategies to benefit these patients. In this review we analyze
the underlying biology and available tools to help clinicians better understand
this increasingly common and specific disease.'
- '[YEAR_RANGE] 2020-2024 [TEXT] PURPOSE: Secondary breast cancer is a frequent
late adverse event of mediastinal Hodgkin lymphoma radiotherapy. Secondary breast
cancers overwhelmingly correspond to ductal carcinoma and develop from the glandular
mammary tissue. In addition, during childhood, radiation overexposure of the glandular
tissue may lead to a late breast hypotrophy at adult age. The aim of this study
was to evaluate the radiation exposure to the glandular tissue in patients treated
for mediastinal Hodgkin lymphoma with intensity-modulated proton therapy, in order
to evaluate the potential dosimetric usefulness of its delineation for breast
sparing. MATERIALS AND METHODS: Sixteen consecutive intermediate-risk mediastinal
female patients with Hodgkin lymphoma treated with consolidation radiation with
deep inspiration breath hold intensity-modulated proton therapy to the total dose
of 30Gy were included. Breasts were delineated according to the European Society
for Radiotherapy and Oncology guidelines for treatment optimization ("clinical
organ at risk"). The glandular tissue ("glandular organ at risk") was retrospectively
contoured on the initial simulation CT scans based on Hounsfield unit (HU) values,
using a range between -80HU and 500HU. RESULTS: The mean and maximum doses delivered
to the glandular organ at risk were significantly lower than the mean and maximum
doses delivered to the clinical organ at risk, but were statistically correlated.
Glandular organ at risk volumes were significantly smaller. CONCLUSION: Optimizing
the treatment plans on the clinical breast contours will systematically lead to
overestimation of the dose received to the glandular tissue and, consequently,
to an indistinct and involuntary improved glandular tissue sparing. As such, our
findings do not support the consideration of the glandular tissue as an additional
organ at risk when planning intensity-modulated proton therapy for mediastinal
Hodgkin lymphoma in female patients.'
- '[YEAR_RANGE] 2020-2024 [TEXT] BACKGROUND: There is an urgent need to develop
an efficient therapeutic strategy for heart failure with preserved ejection fraction
(HFpEF), which is mediated by phenotypic changes in cardiac macrophages. We previously
reported that vitamin B-6 inhibits macrophage-mediated inflammasome activation.
OBJECTIVES: We sought to examine whether the prophylactic use of vitamin B-6 prevents
HFpEF. METHODS: HFpEF model was elicited by a combination of high-fat diet and
Nω-nitro-l-arginine methyl ester supplement in mice. Cardiac function was assessed
using conventional echocardiography and Doppler imaging. Immunohistochemistry
and immunoblotting were used to detect changes in the macrophage phenotype and
myocardial remodeling-related molecules. RESULTS: Co-administration of vitamin
B-6 with HFpEF mice mitigated HFpEF phenotypes, including diastolic dysfunction,
cardiac macrophage phenotypic shifts, fibrosis, and hypertrophy. Echocardiographic
improvements were observed, with the E/E'' ratio decreasing from 42.0 to 21.6
and the E/A ratio improving from 2.13 to 1.17. The exercise capacity also increased
from 295.3 to 657.7 min. However, these beneficial effects were negated in downstream
of kinase (DOK) 3-deficient mice. Mechanistically, vitamin B-6 increased DOK3
protein concentrations and inhibited macrophage phenotypic changes, which were
abrogated by an AMP-activated protein kinase inhibitor. CONCLUSIONS: Vitamin B-6
increases DOK3 signaling to lower risk of HFpEF by inhibiting phenotypic changes
in cardiac macrophages.'
- source_sentence: '[YEAR_RANGE] 2020-2024 [TEXT] Resolving phylogenetic relationships
and taxonomic revision in the Pseudogastromyzon (Cypriniformes, Gastromyzonidae)
genus: molecular and morphological evidence for a new genus, Labigastromyzon.'
sentences:
- '[YEAR_RANGE] 2020-2024 [TEXT] Bats contain a diverse spectrum of viral species
in their bodies. The RNA virus family Paramyxoviridae tends to infect several
vertebrate species, which are accountable for a variety of devastating infections
in both humans and animals. Viruses of this kind include measles, mumps, and Hendra.
Some synonymous codons are favoured over others in mRNAs during gene-to-protein
synthesis process. Such phenomenon is termed as codon usage bias (CUB). Our research
emphasized many aspects that shape the CUB of genes in the Paramyxoviridae family
found in bats. Here, the nitrogenous base A occurred the most. AT was found to
be abundant in the coding sequences of the Paramyxoviridae family. RSCU data revealed
that A or T ending codons occurred more frequently than predicted. Furthermore,
3 overrepresented codons (CAT, AGA, and GCA) and 7 underrepresented codons (CCG,
TCG, CGC, CGG, CGT, GCG and ACG) were detected in the viral genomes. Correspondence
analysis, neutrality plot, and parity plots highlight the combined impact of mutational
pressure and natural selection on CUB. The neutrality plot of GC12 against GC3
yielded a regression coefficient value of 0.366, indicating that natural selection
had a significant (63.4 %) impact. Moreover, RNA editing analysis was done, which
revealed the highest frequency of C to T mutations. The results of our research
revealed the pattern of codon usage and RNA editing sites in Paramyxoviridae genomes.'
- '[YEAR_RANGE] 2020-2024 [TEXT] OBJECTIVE: The preoperative inclination angle of
mandibular incisors was crucial for surgical and postoperative stability while
the effect of proclined mandibular incisors on skeletal stability has not been
investigated. This study aimed to evaluate the effects of differences in presurgical
mandibular incisor inclination on skeletal stability after orthognathic surgery
in patients with skeletal Class III malocclusion. METHODS: A retrospective cohort
study of 80 consecutive patients with skeletal Class III malocclusion who underwent
bimaxillary orthognathic surgery was conducted. According to incisor mandibular
plane angle (IMPA), patients were divided into 3 groups: retroclined inclination
(IMPA < 87°), normal inclination (87° ≤ IMPA < 93°) and proclined inclination
(IMPA ≥ 93°). Preoperative characteristics, surgical changes and postoperative
stability were compared based on lateral cephalograms obtained 1 week before surgery
(T0), 1 week after surgery (T1), and at 6 to 12 months postoperatively (T2). RESULTS:
The mandible demonstrated a forward and upward relapse in all three groups. No
significant differences in skeletal relapse were observed in the 3 groups of patients.
However, the proclined inclination group showed a negative overbite tendency postoperatively
compared with the other two groups and a clinically significant mandibular relapse
pattern. Proclined IMPA both pre- and postoperatively was correlated with mandibular
relapse. CONCLUSION: Sufficient presurgical mandibular incisor decompensation
was of crucial importance for the maintenance of skeletal stability in patients
with skeletal Class III malocclusion who subsequently underwent orthognathic surgery.'
- '[YEAR_RANGE] 2020-2024 [TEXT] The Pseudogastromyzon genus, consisting of species
predominantly distributed throughout southeastern China, has garnered increasing
market attention in recent years due to its ornamental appeal. However, the overlapping
diagnostic attributes render the commonly accepted criteria for interspecific
identification unreliable, leaving the phylogenetic relationships among Pseudogastromyzon
species unexplored. In the present study, we undertake molecular phylogenetic
and morphological examinations of the Pseudogastromyzon genus. Our phylogenetic
analysis of mitochondrial genes distinctly segregated Pseudogastromyzon species
into two clades: the Pseudogastromyzon clade and the Labigastromyzon clade. A
subsequent morphological assessment revealed that the primary dermal ridge (specifically,
the second ridge) within the labial adhesive apparatus serves as an effective
and precise interspecific diagnostic characteristic. Moreover, the distributional
ranges of Pseudogastromyzon and Labigastromyzon are markedly distinct, exhibiting
only a narrow area of overlap. Considering the morphological heterogeneity of
the labial adhesive apparatus and the substantial division within the molecular
phylogeny, we advocate for the elevation of the Labigastromyzon subgenus to the
status of a separate genus. Consequently, we have ascertained the validity of
the Pseudogastromyzon and Labigastromyzon species, yielding a total of six valid
species. To facilitate future research, we present comprehensive descriptions
of the redefined species and introduce novel identification keys.'
- source_sentence: '[YEAR_RANGE] 2020-2024 [TEXT] PCa-RadHop: A transparent and lightweight
feed-forward method for clinically significant prostate cancer segmentation.'
sentences:
- '[YEAR_RANGE] 2020-2024 [TEXT] According to the importance of time in treatment
of thrombosis disorders, faster than current treatments are required. For the
first time, this research discloses a novel strategy for rapid dissolution of
blood clots by encapsulation of a fibrinolytic (Reteplase) into a Thrombin sensitive
shell formed by polymerization of acrylamide monomers and bisacryloylated peptide
as crosslinker. Degradability of the peptide units in exposure to Thrombin, creates
the Thrombin-sensitive Reteplase nanocapsules (TSRNPs) as a triggered release
system. Accelerated thrombolysis was achieved by combining three approaches including:
deep penetration of TSRNPs into the blood clots, changing the clot dissolution
mechanism by altering the distribution pattern of TSRNPs to 3D intra-clot distribution
(based on the distributed intra-clot thrombolysis (DIT) model) instead of peripheral
and unidirectional distribution of unencapsulated fibrinolytics and, enzyme-stimulated
release of the fibrinolytic. Ex-vivo study was carried out by an occluded tube
model that mimics in-vivo brain stroke as an emergency situation where faster
treatment in short time is a golden key. In in vivo, efficacy of the developed
formulation was confirmed by PET scan and laser Doppler flowmetry (LDF). As the
most important achievements, 40.0 ± 0.7 (n = 3) % and 37.0 ± 0.4 (n = 3) % reduction
in the thrombolysis time (faster reperfusion) were observed by ex-vivo and in-vivo
experiments, respectively. Higher blood flow and larger digestion mass of clot
at similar times in comparison to non-encapsulated Reteplase were observed that
means more effective thrombolysis by the developed strategy.'
- '[YEAR_RANGE] 2020-2024 [TEXT] Prostate Cancer is one of the most frequently occurring
cancers in men, with a low survival rate if not early diagnosed. PI-RADS reading
has a high false positive rate, thus increasing the diagnostic incurred costs
and patient discomfort. Deep learning (DL) models achieve a high segmentation
performance, although require a large model size and complexity. Also, DL models
lack of feature interpretability and are perceived as "black-boxes" in the medical
field. PCa-RadHop pipeline is proposed in this work, aiming to provide a more
transparent feature extraction process using a linear model. It adopts the recently
introduced Green Learning (GL) paradigm, which offers a small model size and low
complexity. PCa-RadHop consists of two stages: Stage-1 extracts data-driven radiomics
features from the bi-parametric Magnetic Resonance Imaging (bp-MRI) input and
predicts an initial heatmap. To reduce the false positive rate, a subsequent stage-2
is introduced to refine the predictions by including more contextual information
and radiomics features from each already detected Region of Interest (ROI). Experiments
on the largest publicly available dataset, PI-CAI, show a competitive performance
standing of the proposed method among other deep DL models, achieving an area
under the curve (AUC) of 0.807 among a cohort of 1,000 patients. Moreover, PCa-RadHop
maintains orders of magnitude smaller model size and complexity.'
- '[YEAR_RANGE] 2020-2024 [TEXT] OBJECTIVE: To evaluate rates of remission, recovery,
relapse, and recurrence in suicidal youth who participated in a clinical trial
comparing Dialectical Behavior Therapy (DBT) and Individual and Group Supportive
Therapy (IGST). METHOD: Participants were 173 youth, aged 12 to 18 years, with
repetitive self-harm (including at least 1 prior suicide attempt [SA]) and elevated
suicidal ideation (SI). Participants received 6 months of DBT or IGST and were
followed for 6 months post-treatment. The sample was 95% female, 56.4% White,
and 27.49% Latina. Remission was defined as absence of SA or nonsuicidal self-injury
(NSSI) across one 3-month interval; recovery was defined across 2 or more consecutive
intervals. Relapse and recurrence were defined as SA or NSSI following remission
or recovery. Cross-tabulation with χ2 was used for between-group contrasts. RESULTS:
Over 70% of the sample reported remission of SA at each treatment and follow-up
interval. There were significantly higher rates of remission and recovery and
lower rates of relapse and recurrence for SA in DBT than for IGST. Across treatments
and time points, SA had higher remission and recovery rates and lower relapse
and recurrence rates than NSSI. There were no significant differences in NSSI
remission between conditions; however, participants receiving DBT had significantly
higher NSSI recovery rates than those receiving IGST for the 3- to 9-month, 3-
to 12-month, and 6- to 12-month intervals. CONCLUSION: Results showed higher percentages
of SA remission and recovery for DBT as compared to IGST. NSSI was less likely
to remit than SA. PLAIN LANGUAGE SUMMARY: This study examined rates of remission,
recovery, relapse, and recurrence of suicide attempts (SA) and nonsuicidal self-injury
(NSSI) among the participants in the CARES Study, a randomized clinical trial
of 6 months of Dialectical Behavior Therapy or Individual and Group Supportive
Therapy. 173 youth aged 12 to 18 years participated in the study and were followed
for 6 months post treatment. Over 70% of the sample reported remission of SA at
each treatment and follow-up interval. There were significantly higher rates of
remission and recovery and lower rates of relapse and recurrence for SA among
participants who received Dialectical Behavioral Therapy. Across both treatments,
remission and recovery rates were lower and relapse and recurrence rates were
higher for NSSI than for SA. These results underscore the value of Dialectical
Behavioral Therapy as a first line treatment for youth at high risk for suicide.
DIVERSITY & INCLUSION STATEMENT: We worked to ensure race, ethnic, and/or other
types of diversity in the recruitment of human participants. CLINICAL TRIAL REGISTRATION
INFORMATION: Collaborative Adolescent Research on Emotions and Suicide (CARES);
https://www. CLINICALTRIALS: gov/; NCT01528020.'
- source_sentence: '[YEAR_RANGE] 2020-2024 [TEXT] Predicting Recovery After Concussion
in Pediatric Patients: A Meta-Analysis.'
sentences:
- '[YEAR_RANGE] 2020-2024 [TEXT] OBJECTIVE: The authors examined licensing requirements
for select children''s behavioral health care providers. METHODS: Statutes and
regulations as of October 2021 were reviewed for licensed clinical social workers,
licensed professional counselors, and licensed marriage and family therapists
for all 50 U.S. states and the District of Columbia. RESULTS: All jurisdictions
had laws regarding postgraduate training and license portability. No jurisdiction
included language about specialized postgraduate training related to serving children
and families or cultural competence. Other policies that related to the structure,
composition, and authority of licensing boards varied across states and licensure
types. CONCLUSIONS: In their efforts to address barriers to licensure, expand
the workforce, and ensure that children have access to high-quality and culturally
responsive care, states could consider their statutes and regulations.'
- '[YEAR_RANGE] 2020-2024 [TEXT] Magnetic Resonance Imaging (MRI) plays a pivotal
role in the accurate measurement of brain subcortical structures in macaques,
which is crucial for unraveling the complexities of brain structure and function,
thereby enhancing our understanding of neurodegenerative diseases and brain development.
However, due to significant differences in brain size, structure, and imaging
characteristics between humans and macaques, computational tools developed for
human neuroimaging studies often encounter obstacles when applied to macaques.
In this context, we propose an Anatomy Attentional Fusion Network (AAF-Net), which
integrates multimodal MRI data with anatomical constraints in a multi-scale framework
to address the challenges posed by the dynamic development, regional heterogeneity,
and age-related size variations of the juvenile macaque brain, thus achieving
precise subcortical segmentation. Specifically, we generate a Signed Distance
Map (SDM) based on the initial rough segmentation of the subcortical region by
a network as an anatomical constraint, providing comprehensive information on
positions, structures, and morphology. Then we construct AAF-Net to fully fuse
the SDM anatomical constraints and multimodal images for refined segmentation.
To thoroughly evaluate the performance of our proposed tool, over 700 macaque
MRIs from 19 datasets were used in this study. Specifically, we employed two manually
labeled longitudinal macaque datasets to develop the tool and complete four-fold
cross-validations. Furthermore, we incorporated various external datasets to demonstrate
the proposed tool''s generalization capabilities and promise in brain development
research. We have made this tool available as an open-source resource at https://github.com/TaoZhong11/Macaque_subcortical_segmentation
for direct application.'
- '[YEAR_RANGE] 2020-2024 [TEXT] CONTEXT: Prognostic prediction models (PPMs) can
help clinicians predict outcomes. OBJECTIVE: To critically examine peer-reviewed
PPMs predicting delayed recovery among pediatric patients with concussion. DATA
SOURCES: Ovid Medline, Embase, Ovid PsycInfo, Web of Science Core Collection,
Cumulative Index to Nursing and Allied Health Literature, Cochrane Library, Google
Scholar. STUDY SELECTION: The study had to report a PPM for pediatric patients
to be used within 28 days of injury to estimate risk of delayed recovery at 28
days to 1 year postinjury. Studies had to have at least 30 participants. DATA
EXTRACTION: The Critical Appraisal and Data Extraction for Systematic Reviews
of Prediction Modeling Studies checklist was completed. RESULTS: Six studies of
13 PPMs were included. These studies primarily reflected male patients in late
childhood or early adolescence presenting to an emergency department meeting the
Concussion in Sport Group concussion criteria. No study authors used the same
outcome definition nor evaluated the clinical utility of a model. All studies
demonstrated high risk of bias. Quality of evidence was best for the Predicting
and Preventing Postconcussive Problems in Pediatrics (5P) clinical risk score.
LIMITATIONS: No formal PPM Grading of Recommendations, Assessment, Development,
and Evaluations (GRADE) process exists. CONCLUSIONS: The 5P clinical risk score
may be considered for clinical use. Rigorous external validations, particularly
in other settings, are needed. The remaining PPMs require external validation.
Lack of consensus regarding delayed recovery criteria limits these PPMs.'
- source_sentence: '[YEAR_RANGE] 2020-2024 [TEXT] Intraoperative Monitoring of the
External Urethral Sphincter Reflex: A Novel Adjunct to Bulbocavernosus Reflex
Neuromonitoring for Protecting the Sacral Neural Pathways Responsible for Urination,
Defecation and Sexual Function.'
sentences:
- '[YEAR_RANGE] 2020-2024 [TEXT] Early menarche has been associated with adverse
health outcomes, such as depressive symptoms. Discovering effect modifiers across
these conditions in the pediatric population is a constant challenge. We tested
whether movement behaviours modified the effect of the association between early
menarche and depression symptoms among adolescents. This cross-sectional study
included 2031 females aged 15-19 years across all Brazilian geographic regions.
Data were collected using a self-administered questionnaire; 30.5% (n = 620) reported
having experienced menarche before age 12 years (that is, early menarche). We
used the Patient Health Questionnaire (PHQ-9) to evaluate depressive symptoms.
Accruing any moderate-vigorous physical activity during leisure time, limited
recreational screen time, and having good sleep quality were the exposures investigated.
Adolescents who experienced early menarche and met one (B: -4.45, 95% CI: (-5.38,
-3.51)), two (B: -6.07 (-7.02, -5.12)), or three (B: -6.49 (-7.76, -5.21)), and
adolescents who experienced not early menarche and met one (B: -5.33 (-6.20; -4.46)),
two (B: -6.12 (-6.99; -5.24)), or three (B: -6.27 (-7.30; -5.24)) of the movement
behaviour targets had lower PHQ-9 scores for depression symptoms than adolescents
who experienced early menarche and did not meet any of the movement behaviours.
The disparities in depressive symptoms among the adolescents (early menarche versus
not early menarche) who adhered to all three target behaviours were not statistically
significant (B: 0.41 (-0.19; 1.01)). Adherence to movement behaviours modified
the effect of the association between early menarche and depression symptoms.'
- '[YEAR_RANGE] 2020-2024 [TEXT] PURPOSE: Intraoperative bulbocavernosus reflex
neuromonitoring has been utilized to protect bowel, bladder, and sexual function,
providing a continuous functional assessment of the somatic sacral nervous system
during surgeries where it is at risk. Bulbocavernosus reflex data may also provide
additional functional insight, including an evaluation for spinal shock, distinguishing
upper versus lower motor neuron injury (conus versus cauda syndromes) and prognosis
for postoperative bowel and bladder function. Continuous intraoperative bulbocavernosus
reflex monitoring has been utilized to provide the surgeon with an ongoing functional
assessment of the anatomical elements involved in the S2-S4 mediated reflex arc
including the conus, cauda equina and pudendal nerves. Intraoperative bulbocavernosus
reflex monitoring typically includes the electrical activation of the dorsal nerves
of the genitals to initiate the afferent component of the reflex, followed by
recording the resulting muscle response using needle electromyography recordings
from the external anal sphincter. METHODS: Herein we describe a complementary
and novel technique that includes recording electromyography responses from the
external urethral sphincter to monitor the external urethral sphincter reflex.
Specialized foley catheters embedded with recording electrodes have recently become
commercially available that provide the ability to perform intraoperative external
urethral sphincter muscle recordings. RESULTS: We describe technical details and
the potential utility of incorporating external urethral sphincter reflex recordings
into existing sacral neuromonitoring paradigms to provide redundant yet complementary
data streams. CONCLUSIONS: We present two illustrative neurosurgical oncology
cases to demonstrate the utility of the external urethral sphincter reflex technique
in the setting of the necessary surgical sacrifice of sacral nerve roots.'
- '[YEAR_RANGE] 2020-2024 [TEXT] BACKGROUND: Limited data are available on the appropriate
choice of blood pressure management strategy for patients with acute basilar artery
occlusion assessed by the standard deviation (SD). Multivariate logistic models
were used to investigate the association between BPV, the primary outcome (futile
recanalization, 90-day modified Rankin Scale score 3-6), and the secondary outcome
(30-day mortality). Subgroup analysis was performed as a sensitivity test. RESULTS:
Futile recanalization occurred in 60 (56 %) patients, while 26 (24 %) patients
died within 30 days. In the fully adjusted model, MAP SD was associated with a
higher risk of futile recanalization (OR adj=1.36, per 1 mmHg increase, 95 % CI:
1.09-1.69, P=0.006) and 30-day mortality (OR adj=1.56, per 1 mmHg increase, 95
% CI: 1.20-2.04, P=0.001). A significant interaction between MAP SD and the lack
of hypertension history on futile recanalization (P<0.05) was observed. CONCLUSIONS:
Among recanalized acute BAO ischemic patients, higher blood pressure variability
during the first 24 h after MT was associated with worse outcomes. This association
was stronger in patients without a history of hypertension.'
---
# SentenceTransformer
This is a [sentence-transformers](https://www.SBERT.net) model trained on the parquet dataset. It maps sentences & paragraphs to a 384-dimensional dense vector space and can be used for semantic textual similarity, semantic search, paraphrase mining, text classification, clustering, and more.
## Model Details
### Model Description
- **Model Type:** Sentence Transformer
<!-- - **Base model:** [Unknown](https://huggingface.co/unknown) -->
- **Maximum Sequence Length:** 1024 tokens
- **Output Dimensionality:** 384 tokens
- **Similarity Function:** Cosine Similarity
- **Training Dataset:**
- parquet
<!-- - **Language:** Unknown -->
<!-- - **License:** Unknown -->
### Model Sources
- **Documentation:** [Sentence Transformers Documentation](https://sbert.net)
- **Repository:** [Sentence Transformers on GitHub](https://github.com/UKPLab/sentence-transformers)
- **Hugging Face:** [Sentence Transformers on Hugging Face](https://huggingface.co/models?library=sentence-transformers)
### Full Model Architecture
```
SentenceTransformer(
(0): Transformer({'max_seq_length': 1024, 'do_lower_case': False}) with Transformer model: BertModel
(1): Pooling({'word_embedding_dimension': 384, 'pooling_mode_cls_token': False, 'pooling_mode_mean_tokens': True, 'pooling_mode_max_tokens': False, 'pooling_mode_mean_sqrt_len_tokens': False, 'pooling_mode_weightedmean_tokens': False, 'pooling_mode_lasttoken': False, 'include_prompt': True})
)
```
## Usage
### Direct Usage (Sentence Transformers)
First install the Sentence Transformers library:
```bash
pip install -U sentence-transformers
```
Then you can load this model and run inference.
```python
from sentence_transformers import SentenceTransformer
# Download from the 🤗 Hub
model = SentenceTransformer("pankajrajdeo/UMLS-Pubmed-TCE-Epoch-2")
# Run inference
sentences = [
'[YEAR_RANGE] 2020-2024 [TEXT] Intraoperative Monitoring of the External Urethral Sphincter Reflex: A Novel Adjunct to Bulbocavernosus Reflex Neuromonitoring for Protecting the Sacral Neural Pathways Responsible for Urination, Defecation and Sexual Function.',
'[YEAR_RANGE] 2020-2024 [TEXT] PURPOSE: Intraoperative bulbocavernosus reflex neuromonitoring has been utilized to protect bowel, bladder, and sexual function, providing a continuous functional assessment of the somatic sacral nervous system during surgeries where it is at risk. Bulbocavernosus reflex data may also provide additional functional insight, including an evaluation for spinal shock, distinguishing upper versus lower motor neuron injury (conus versus cauda syndromes) and prognosis for postoperative bowel and bladder function. Continuous intraoperative bulbocavernosus reflex monitoring has been utilized to provide the surgeon with an ongoing functional assessment of the anatomical elements involved in the S2-S4 mediated reflex arc including the conus, cauda equina and pudendal nerves. Intraoperative bulbocavernosus reflex monitoring typically includes the electrical activation of the dorsal nerves of the genitals to initiate the afferent component of the reflex, followed by recording the resulting muscle response using needle electromyography recordings from the external anal sphincter. METHODS: Herein we describe a complementary and novel technique that includes recording electromyography responses from the external urethral sphincter to monitor the external urethral sphincter reflex. Specialized foley catheters embedded with recording electrodes have recently become commercially available that provide the ability to perform intraoperative external urethral sphincter muscle recordings. RESULTS: We describe technical details and the potential utility of incorporating external urethral sphincter reflex recordings into existing sacral neuromonitoring paradigms to provide redundant yet complementary data streams. CONCLUSIONS: We present two illustrative neurosurgical oncology cases to demonstrate the utility of the external urethral sphincter reflex technique in the setting of the necessary surgical sacrifice of sacral nerve roots.',
'[YEAR_RANGE] 2020-2024 [TEXT] Early menarche has been associated with adverse health outcomes, such as depressive symptoms. Discovering effect modifiers across these conditions in the pediatric population is a constant challenge. We tested whether movement behaviours modified the effect of the association between early menarche and depression symptoms among adolescents. This cross-sectional study included 2031 females aged 15-19 years across all Brazilian geographic regions. Data were collected using a self-administered questionnaire; 30.5% (n = 620) reported having experienced menarche before age 12 years (that is, early menarche). We used the Patient Health Questionnaire (PHQ-9) to evaluate depressive symptoms. Accruing any moderate-vigorous physical activity during leisure time, limited recreational screen time, and having good sleep quality were the exposures investigated. Adolescents who experienced early menarche and met one (B: -4.45, 95% CI: (-5.38, -3.51)), two (B: -6.07 (-7.02, -5.12)), or three (B: -6.49 (-7.76, -5.21)), and adolescents who experienced not early menarche and met one (B: -5.33 (-6.20; -4.46)), two (B: -6.12 (-6.99; -5.24)), or three (B: -6.27 (-7.30; -5.24)) of the movement behaviour targets had lower PHQ-9 scores for depression symptoms than adolescents who experienced early menarche and did not meet any of the movement behaviours. The disparities in depressive symptoms among the adolescents (early menarche versus not early menarche) who adhered to all three target behaviours were not statistically significant (B: 0.41 (-0.19; 1.01)). Adherence to movement behaviours modified the effect of the association between early menarche and depression symptoms.',
]
embeddings = model.encode(sentences)
print(embeddings.shape)
# [3, 384]
# Get the similarity scores for the embeddings
similarities = model.similarity(embeddings, embeddings)
print(similarities.shape)
# [3, 3]
```
<!--
### Direct Usage (Transformers)
<details><summary>Click to see the direct usage in Transformers</summary>
</details>
-->
<!--
### Downstream Usage (Sentence Transformers)
You can finetune this model on your own dataset.
<details><summary>Click to expand</summary>
</details>
-->
<!--
### Out-of-Scope Use
*List how the model may foreseeably be misused and address what users ought not to do with the model.*
-->
<!--
## Bias, Risks and Limitations
*What are the known or foreseeable issues stemming from this model? You could also flag here known failure cases or weaknesses of the model.*
-->
<!--
### Recommendations
*What are recommendations with respect to the foreseeable issues? For example, filtering explicit content.*
-->
## Training Details
### Training Dataset
#### parquet
* Dataset: parquet
* Size: 26,147,930 training samples
* Columns: <code>anchor</code> and <code>positive</code>
* Approximate statistics based on the first 1000 samples:
| | anchor | positive |
|:--------|:------------------------------------------------------------------------------------|:--------------------------------------------------------------------------------------|
| type | string | string |
| details | <ul><li>min: 28 tokens</li><li>mean: 57.85 tokens</li><li>max: 149 tokens</li></ul> | <ul><li>min: 43 tokens</li><li>mean: 319.08 tokens</li><li>max: 1024 tokens</li></ul> |
* Samples:
| anchor | positive |
|:---------------------------------------------------------------------------------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| <code>[YEAR_RANGE] 1880-1884 [TEXT] ADDRESS OF COL. GARRICK MALLERY, U. S. ARMY.</code> | <code>[YEAR_RANGE] 1880-1884 [TEXT] It may be conceded that after man had all his present faculties, he did not choose between the adoption of voice and gesture, and never with those faculties, was in a state where the one was used, to the absolute exclusion of the other. The epoch, however, to which our speculations relate is that in which he had not reached the present symmetric development of his intellect and of his bodily organs, and the inquiry is: Which mode of communication was earliest adopted to his single wants and informed intelligence? With the voice he could imitate distinictively but few sounds of nature, while with gesture he could exhibit actions, motions, positions, forms, dimensions, directions and distances, with their derivations and analogues. It would seem from this unequal division of capacity that oral speech remained rudimentary long after gesture had become an efficient mode of communication. With due allowance for all purely imitative sounds, and for the spontaneous action of vocal organs under excitement, it appears that the connection between ideas and words is only to be explained by a compact between speaker and hearer which supposes the existence of a prior mode of communication. This was probably by gesture. At least we may accept it as a clew leading out of the labyrinth of philological confusion, and regulating the immemorial quest of man's primitive speech.</code> |
| <code>[YEAR_RANGE] 1880-1884 [TEXT] How TO OBTAIN THE BRAIN OF THE CAT.</code> | <code>[YEAR_RANGE] 1880-1884 [TEXT] How to obtain the Brain of the Cat, (Wilder).-Correction: Page 158, second column, line 7, "grains," should be "grams;" page 159, near middle of 2nd column, "successily," should be "successively;" page 161, the number of Flower's paper is 3.</code> |
| <code>[YEAR_RANGE] 1880-1884 [TEXT] DOLBEAR ON THE NATURE AND CONSTITUTION OF MATTER.</code> | <code>[YEAR_RANGE] 1880-1884 [TEXT] Mr. Dopp desires to make the following correction in his paper in the last issue: "In my article on page 200 of "Science", the expression and should have been and being the velocity of light.</code> |
* Loss: [<code>MultipleNegativesRankingLoss</code>](https://sbert.net/docs/package_reference/sentence_transformer/losses.html#multiplenegativesrankingloss) with these parameters:
```json
{
"scale": 20.0,
"similarity_fct": "cos_sim"
}
```
### Evaluation Dataset
#### parquet
* Dataset: parquet
* Size: 26,147,930 evaluation samples
* Columns: <code>anchor</code> and <code>positive</code>
* Approximate statistics based on the first 1000 samples:
| | anchor | positive |
|:--------|:-----------------------------------------------------------------------------------|:-------------------------------------------------------------------------------------|
| type | string | string |
| details | <ul><li>min: 27 tokens</li><li>mean: 43.78 tokens</li><li>max: 90 tokens</li></ul> | <ul><li>min: 28 tokens</li><li>mean: 315.03 tokens</li><li>max: 847 tokens</li></ul> |
* Samples:
| anchor | positive |
|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| <code>[YEAR_RANGE] 2020-2024 [TEXT] Solubility and thermodynamics of mesalazine in aqueous mixtures of poly ethylene glycol 200/600 at 293.2-313.2K.</code> | <code>[YEAR_RANGE] 2020-2024 [TEXT] In this study, the solubility of mesalazine was investigated in binary solvent mixtures of poly ethylene glycols 200/600 and water at temperatures ranging from 293.2K to 313.2K. The solubility of mesalazine was determined using a shake-flask method, and its concentrations were measured using a UV-Vis spectrophotometer. The obtained solubility data were analyzed using mathematical models including the van't Hoff, Jouyban-Acree, Jouyban-Acree-van't Hoff, mixture response surface, and modified Wilson models. The experimental data obtained for mesalazine dissolution encompassed various thermodynamic properties, including ΔG°, ΔH°, ΔS°, and TΔS°. These properties offer valuable insights into the energetic aspects of the dissolution process and were calculated based on the van't Hoff equation.</code> |
| <code>[YEAR_RANGE] 2020-2024 [TEXT] Safety and efficacy of remimazolam versus propofol during EUS: a multicenter randomized controlled study.</code> | <code>[YEAR_RANGE] 2020-2024 [TEXT] BACKGROUND AND AIMS: Propofol, a widely used sedative in GI endoscopic procedures, is associated with cardiorespiratory suppression. Remimazolam is a novel ultrashort-acting benzodiazepine sedative with rapid onset and minimal cardiorespiratory depression. This study compared the safety and efficacy of remimazolam and propofol during EUS procedures. METHODS: A multicenter randomized controlled study was conducted between October 2022 and March 2023 in patients who underwent EUS procedures. Patients were randomly assigned to receive either remimazolam or propofol as a sedative agent. The primary endpoint was cardiorespiratory adverse events.</code> |
| <code>[YEAR_RANGE] 2020-2024 [TEXT] Ultrasound-Guided Vs Non-Guided Prolotherapy for Internal Derangement of Temporomandibular Joint. A Randomized Clinical Trial.</code> | <code>[YEAR_RANGE] 2020-2024 [TEXT] OBJECTIVES: This randomized clinical trial study aims to compare ultrasound-guided versus non-guided Dextrose 10% injections in patients suffering from internal derangement in the temporomandibular joint (TMJ). MATERIAL AND METHODS: The study population included 22 patients and 43 TMJs suffering from unilateral or bilateral TMJ painful clicking, magnetic resonance imaging (MRI) proved disc displacement with reduction (DDWR), refractory to or failed conservative treatment. The patients were divided randomly into two groups (non-guided and ultrasound (US)-guided groups). The procedure involved injection of 2 mL solution of a mixture of 0.75 mL 0.9% normal saline solution, 0.3 mL 2% lidocaine and 0.75 mL dextrose 10% using a 25G needle in the joint and 1 mL intramuscular injection to the masseter muscle at the most tender point. The Visual Analogue Score (VAS) was used to compare joint pain intensity over four different periods, beginning with pre-injection, 1-, 2-, and 6-months postinjection. RESULTS: Twenty-two patients 5 males (n = 5/22, 22.7%) and 17 females (n = 17/22, 77.2%) were included in this study. The mean age was 27.3 ± 7.4 years (30.2 ± 7.0) for the non-guided group and 24.3 ± 6.9 for the US-guided group. The dextrose injection reduced intensity over time in both groups with statistically significant improvement (P value <.05) at 2 and 6 months in both groups. There was no statistically significant difference in VAS assessment between both groups. CONCLUSION: Intra-articular injection of dextrose 10% for patients with painful clicking and DDWR resulted in reduced pain intensity in both US-guided and non-guided groups with significant symptomatic improvement over time in both groups. US guidance allowed accurate anatomical localization and safe procedure with a single joint puncture.</code> |
* Loss: [<code>MultipleNegativesRankingLoss</code>](https://sbert.net/docs/package_reference/sentence_transformer/losses.html#multiplenegativesrankingloss) with these parameters:
```json
{
"scale": 20.0,
"similarity_fct": "cos_sim"
}
```
### Training Hyperparameters
#### Non-Default Hyperparameters
- `eval_strategy`: steps
- `per_device_train_batch_size`: 128
- `learning_rate`: 2e-05
- `num_train_epochs`: 5
- `max_steps`: 970330
- `log_level`: info
- `fp16`: True
- `dataloader_num_workers`: 16
- `load_best_model_at_end`: True
- `resume_from_checkpoint`: True
#### All Hyperparameters
<details><summary>Click to expand</summary>
- `overwrite_output_dir`: False
- `do_predict`: False
- `eval_strategy`: steps
- `prediction_loss_only`: True
- `per_device_train_batch_size`: 128
- `per_device_eval_batch_size`: 8
- `per_gpu_train_batch_size`: None
- `per_gpu_eval_batch_size`: None
- `gradient_accumulation_steps`: 1
- `eval_accumulation_steps`: None
- `torch_empty_cache_steps`: None
- `learning_rate`: 2e-05
- `weight_decay`: 0.0
- `adam_beta1`: 0.9
- `adam_beta2`: 0.999
- `adam_epsilon`: 1e-08
- `max_grad_norm`: 1.0
- `num_train_epochs`: 5
- `max_steps`: 970330
- `lr_scheduler_type`: linear
- `lr_scheduler_kwargs`: {}
- `warmup_ratio`: 0.0
- `warmup_steps`: 0
- `log_level`: info
- `log_level_replica`: warning
- `log_on_each_node`: True
- `logging_nan_inf_filter`: True
- `save_safetensors`: True
- `save_on_each_node`: False
- `save_only_model`: False
- `restore_callback_states_from_checkpoint`: False
- `no_cuda`: False
- `use_cpu`: False
- `use_mps_device`: False
- `seed`: 42
- `data_seed`: None
- `jit_mode_eval`: False
- `use_ipex`: False
- `bf16`: False
- `fp16`: True
- `fp16_opt_level`: O1
- `half_precision_backend`: auto
- `bf16_full_eval`: False
- `fp16_full_eval`: False
- `tf32`: None
- `local_rank`: 0
- `ddp_backend`: None
- `tpu_num_cores`: None
- `tpu_metrics_debug`: False
- `debug`: []
- `dataloader_drop_last`: False
- `dataloader_num_workers`: 16
- `dataloader_prefetch_factor`: None
- `past_index`: -1
- `disable_tqdm`: False
- `remove_unused_columns`: True
- `label_names`: None
- `load_best_model_at_end`: True
- `ignore_data_skip`: False
- `fsdp`: []
- `fsdp_min_num_params`: 0
- `fsdp_config`: {'min_num_params': 0, 'xla': False, 'xla_fsdp_v2': False, 'xla_fsdp_grad_ckpt': False}
- `fsdp_transformer_layer_cls_to_wrap`: None
- `accelerator_config`: {'split_batches': False, 'dispatch_batches': None, 'even_batches': True, 'use_seedable_sampler': True, 'non_blocking': False, 'gradient_accumulation_kwargs': None}
- `deepspeed`: None
- `label_smoothing_factor`: 0.0
- `optim`: adamw_torch
- `optim_args`: None
- `adafactor`: False
- `group_by_length`: False
- `length_column_name`: length
- `ddp_find_unused_parameters`: None
- `ddp_bucket_cap_mb`: None
- `ddp_broadcast_buffers`: False
- `dataloader_pin_memory`: True
- `dataloader_persistent_workers`: False
- `skip_memory_metrics`: True
- `use_legacy_prediction_loop`: False
- `push_to_hub`: False
- `resume_from_checkpoint`: True
- `hub_model_id`: None
- `hub_strategy`: every_save
- `hub_private_repo`: False
- `hub_always_push`: False
- `gradient_checkpointing`: False
- `gradient_checkpointing_kwargs`: None
- `include_inputs_for_metrics`: False
- `eval_do_concat_batches`: True
- `fp16_backend`: auto
- `push_to_hub_model_id`: None
- `push_to_hub_organization`: None
- `mp_parameters`:
- `auto_find_batch_size`: False
- `full_determinism`: False
- `torchdynamo`: None
- `ray_scope`: last
- `ddp_timeout`: 1800
- `torch_compile`: False
- `torch_compile_backend`: None
- `torch_compile_mode`: None
- `dispatch_batches`: None
- `split_batches`: None
- `include_tokens_per_second`: False
- `include_num_input_tokens_seen`: False
- `neftune_noise_alpha`: None
- `optim_target_modules`: None
- `batch_eval_metrics`: False
- `eval_on_start`: False
- `eval_use_gather_object`: False
- `batch_sampler`: batch_sampler
- `multi_dataset_batch_sampler`: proportional
</details>
### Training Logs
<details><summary>Click to expand</summary>
| Epoch | Step | Training Loss | Validation Loss |
|:------:|:------:|:-------------:|:---------------:|
| 0.0000 | 1 | 5.9163 | - |
| 0.0052 | 1000 | 0.6371 | - |
| 0.0103 | 2000 | 0.1741 | - |
| 0.0155 | 3000 | 0.1606 | - |
| 0.0206 | 4000 | 0.1496 | - |
| 0.0258 | 5000 | 0.111 | - |
| 0.0309 | 6000 | 0.1198 | - |
| 0.0361 | 7000 | 0.1047 | - |
| 0.0412 | 8000 | 0.1002 | - |
| 0.0464 | 9000 | 0.0991 | - |
| 0.0515 | 10000 | 0.1142 | - |
| 0.0567 | 11000 | 0.1027 | - |
| 0.0618 | 12000 | 0.0752 | - |
| 0.0670 | 13000 | 0.1036 | - |
| 0.0721 | 14000 | 0.1114 | - |
| 0.0773 | 15000 | 0.0701 | - |
| 0.0824 | 16000 | 0.1623 | - |
| 0.0876 | 17000 | 0.0727 | - |
| 0.0928 | 18000 | 0.1121 | - |
| 0.0979 | 19000 | 0.0684 | - |
| 0.1031 | 20000 | 0.1327 | - |
| 0.1082 | 21000 | 0.0755 | - |
| 0.1134 | 22000 | 0.1293 | - |
| 0.1185 | 23000 | 0.0661 | - |
| 0.1237 | 24000 | 0.0797 | - |
| 0.1288 | 25000 | 0.063 | - |
| 0.1340 | 26000 | 0.1324 | - |
| 0.1391 | 27000 | 0.0708 | - |
| 0.1443 | 28000 | 0.1386 | - |
| 0.1494 | 29000 | 0.0691 | - |
| 0.1546 | 30000 | 0.143 | - |
| 0.1597 | 31000 | 0.0644 | - |
| 0.1649 | 32000 | 0.1065 | - |
| 0.1700 | 33000 | 0.1089 | - |
| 0.1752 | 34000 | 0.0737 | - |
| 0.1804 | 35000 | 0.1431 | - |
| 0.1855 | 36000 | 0.069 | - |
| 0.1907 | 37000 | 0.0756 | - |
| 0.1958 | 38000 | 0.1252 | - |
| 0.2010 | 39000 | 0.0768 | - |
| 0.2061 | 40000 | 0.1255 | - |
| 0.2113 | 41000 | 0.0849 | - |
| 0.2164 | 42000 | 0.072 | - |
| 0.2216 | 43000 | 0.1171 | - |
| 0.2267 | 44000 | 0.072 | - |
| 0.2319 | 45000 | 0.0818 | - |
| 0.2370 | 46000 | 0.0988 | - |
| 0.2422 | 47000 | 0.066 | - |
| 0.2473 | 48000 | 0.0829 | - |
| 0.2525 | 49000 | 0.0907 | - |
| 0.2576 | 50000 | 0.075 | - |
| 0.2628 | 51000 | 0.0653 | - |
| 0.2679 | 52000 | 0.0667 | - |
| 0.2731 | 53000 | 0.0906 | - |
| 0.2783 | 54000 | 0.0803 | - |
| 0.2834 | 55000 | 0.0568 | - |
| 0.2886 | 56000 | 0.0665 | - |
| 0.2937 | 57000 | 0.0629 | - |
| 0.2989 | 58000 | 0.0665 | - |
| 0.3040 | 59000 | 0.0601 | - |
| 0.3092 | 60000 | 0.0761 | - |
| 0.3143 | 61000 | 0.0472 | - |
| 0.3195 | 62000 | 0.0527 | - |
| 0.3246 | 63000 | 0.0585 | - |
| 0.3298 | 64000 | 0.0699 | - |
| 0.3349 | 65000 | 0.0687 | - |
| 0.3401 | 66000 | 0.0541 | - |
| 0.3452 | 67000 | 0.0413 | - |
| 0.3504 | 68000 | 0.055 | - |
| 0.3555 | 69000 | 0.0706 | - |
| 0.3607 | 70000 | 0.0805 | - |
| 0.3659 | 71000 | 0.0884 | - |
| 0.3710 | 72000 | 0.0359 | - |
| 0.3762 | 73000 | 0.0443 | - |
| 0.3813 | 74000 | 0.0543 | - |
| 0.3865 | 75000 | 0.045 | - |
| 0.3916 | 76000 | 0.1031 | - |
| 0.3968 | 77000 | 0.0535 | - |
| 0.4019 | 78000 | 0.0661 | - |
| 0.4071 | 79000 | 0.0353 | - |
| 0.4122 | 80000 | 0.06 | - |
| 0.4174 | 81000 | 0.0743 | - |
| 0.4225 | 82000 | 0.0439 | - |
| 0.4277 | 83000 | 0.0484 | - |
| 0.4328 | 84000 | 0.0643 | - |
| 0.4380 | 85000 | 0.0308 | - |
| 0.4431 | 86000 | 0.0412 | - |
| 0.4483 | 87000 | 0.0464 | - |
| 0.4535 | 88000 | 0.0713 | - |
| 0.4586 | 89000 | 0.0575 | - |
| 0.4638 | 90000 | 0.0461 | - |
| 0.4689 | 91000 | 0.0358 | - |
| 0.4741 | 92000 | 0.0413 | - |
| 0.4792 | 93000 | 0.0481 | - |
| 0.4844 | 94000 | 0.0473 | - |
| 0.4895 | 95000 | 0.082 | - |
| 0.4947 | 96000 | 0.0313 | - |
| 0.4998 | 97000 | 0.0365 | - |
| 0.5050 | 98000 | 0.0338 | - |
| 0.5101 | 99000 | 0.0364 | - |
| 0.5153 | 100000 | 0.0288 | - |
| 0.5204 | 101000 | 0.0421 | - |
| 0.5256 | 102000 | 0.0444 | - |
| 0.5307 | 103000 | 0.0242 | - |
| 0.5359 | 104000 | 0.0318 | - |
| 0.5411 | 105000 | 0.0285 | - |
| 0.5462 | 106000 | 0.0231 | - |
| 0.5514 | 107000 | 0.0534 | - |
| 0.5565 | 108000 | 0.0469 | - |
| 0.5617 | 109000 | 0.031 | - |
| 0.5668 | 110000 | 0.0376 | - |
| 0.5720 | 111000 | 0.0403 | - |
| 0.5771 | 112000 | 0.0408 | - |
| 0.5823 | 113000 | 0.0284 | - |
| 0.5874 | 114000 | 0.0344 | - |
| 0.5926 | 115000 | 0.0469 | - |
| 0.5977 | 116000 | 0.0304 | - |
| 0.6029 | 117000 | 0.0676 | - |
| 0.6080 | 118000 | 0.0396 | - |
| 0.6132 | 119000 | 0.0337 | - |
| 0.6183 | 120000 | 0.039 | - |
| 0.6235 | 121000 | 0.0286 | - |
| 0.6286 | 122000 | 0.0404 | - |
| 0.6338 | 123000 | 0.0383 | - |
| 0.6390 | 124000 | 0.046 | - |
| 0.6441 | 125000 | 0.0403 | - |
| 0.6493 | 126000 | 0.0502 | - |
| 0.6544 | 127000 | 0.0424 | - |
| 0.6596 | 128000 | 0.0424 | - |
| 0.6647 | 129000 | 0.0338 | - |
| 0.6699 | 130000 | 0.0262 | - |
| 0.6750 | 131000 | 0.0203 | - |
| 0.6802 | 132000 | 0.0405 | - |
| 0.6853 | 133000 | 0.0374 | - |
| 0.6905 | 134000 | 0.0329 | - |
| 0.6956 | 135000 | 0.0287 | - |
| 0.7008 | 136000 | 0.0366 | - |
| 0.7059 | 137000 | 0.0344 | - |
| 0.7111 | 138000 | 0.0402 | - |
| 0.7162 | 139000 | 0.0331 | - |
| 0.7214 | 140000 | 0.0404 | - |
| 0.7266 | 141000 | 0.0433 | - |
| 0.7317 | 142000 | 0.032 | - |
| 0.7369 | 143000 | 0.0281 | - |
| 0.7420 | 144000 | 0.0265 | - |
| 0.7472 | 145000 | 0.0282 | - |
| 0.7523 | 146000 | 0.0233 | - |
| 0.7575 | 147000 | 0.0291 | - |
| 0.7626 | 148000 | 0.0358 | - |
| 0.7678 | 149000 | 0.0343 | - |
| 0.7729 | 150000 | 0.0292 | - |
| 0.7781 | 151000 | 0.0359 | - |
| 0.7832 | 152000 | 0.0361 | - |
| 0.7884 | 153000 | 0.0289 | - |
| 0.7935 | 154000 | 0.0374 | - |
| 0.7987 | 155000 | 0.0341 | - |
| 0.8038 | 156000 | 0.0353 | - |
| 0.8090 | 157000 | 0.033 | - |
| 0.8142 | 158000 | 0.0291 | - |
| 0.8193 | 159000 | 0.0362 | - |
| 0.8245 | 160000 | 0.0355 | - |
| 0.8296 | 161000 | 0.026 | - |
| 0.8348 | 162000 | 0.0237 | - |
| 0.8399 | 163000 | 0.0175 | - |
| 0.8451 | 164000 | 0.0219 | - |
| 0.8502 | 165000 | 0.0227 | - |
| 0.8554 | 166000 | 0.0177 | - |
| 0.8605 | 167000 | 0.0239 | - |
| 0.8657 | 168000 | 0.0223 | - |
| 0.8708 | 169000 | 0.0219 | - |
| 0.8760 | 170000 | 0.0248 | - |
| 0.8811 | 171000 | 0.0237 | - |
| 0.8863 | 172000 | 0.0262 | - |
| 0.8914 | 173000 | 0.026 | - |
| 0.8966 | 174000 | 0.0228 | - |
| 0.9018 | 175000 | 0.0259 | - |
| 0.9069 | 176000 | 0.0232 | - |
| 0.9121 | 177000 | 0.0268 | - |
| 0.9172 | 178000 | 0.0228 | - |
| 0.9224 | 179000 | 0.0198 | - |
| 0.9275 | 180000 | 0.0183 | - |
| 0.9327 | 181000 | 0.022 | - |
| 0.9378 | 182000 | 0.0227 | - |
| 0.9430 | 183000 | 0.021 | - |
| 0.9481 | 184000 | 0.0211 | - |
| 0.9533 | 185000 | 0.0216 | - |
| 0.9584 | 186000 | 0.0209 | - |
| 0.9636 | 187000 | 0.0191 | - |
| 0.9687 | 188000 | 0.0188 | - |
| 0.9739 | 189000 | 0.0203 | - |
| 0.9790 | 190000 | 0.0203 | - |
| 0.9842 | 191000 | 0.0313 | - |
| 0.9893 | 192000 | 0.0213 | - |
| 0.9945 | 193000 | 0.0164 | - |
| 0.9997 | 194000 | 0.0181 | - |
| 1.0000 | 194066 | - | 0.0006 |
| 1.0048 | 195000 | 0.2333 | - |
| 1.0100 | 196000 | 0.0787 | - |
| 1.0151 | 197000 | 0.0848 | - |
| 1.0203 | 198000 | 0.0813 | - |
| 1.0254 | 199000 | 0.0624 | - |
| 1.0306 | 200000 | 0.0691 | - |
| 1.0357 | 201000 | 0.0596 | - |
| 1.0409 | 202000 | 0.0575 | - |
| 1.0460 | 203000 | 0.0573 | - |
| 1.0512 | 204000 | 0.0684 | - |
| 1.0563 | 205000 | 0.0507 | - |
| 1.0615 | 206000 | 0.0548 | - |
| 1.0666 | 207000 | 0.0607 | - |
| 1.0718 | 208000 | 0.0713 | - |
| 1.0769 | 209000 | 0.0425 | - |
| 1.0821 | 210000 | 0.113 | - |
| 1.0873 | 211000 | 0.0432 | - |
| 1.0924 | 212000 | 0.0727 | - |
| 1.0976 | 213000 | 0.0431 | - |
| 1.1027 | 214000 | 0.0909 | - |
| 1.1079 | 215000 | 0.0453 | - |
| 1.1130 | 216000 | 0.087 | - |
| 1.1182 | 217000 | 0.0442 | - |
| 1.1233 | 218000 | 0.0503 | - |
| 1.1285 | 219000 | 0.0413 | - |
| 1.1336 | 220000 | 0.0899 | - |
| 1.1388 | 221000 | 0.0463 | - |
| 1.1439 | 222000 | 0.0956 | - |
| 1.1491 | 223000 | 0.0452 | - |
| 1.1542 | 224000 | 0.098 | - |
| 1.1594 | 225000 | 0.0426 | - |
| 1.1645 | 226000 | 0.0597 | - |
| 1.1697 | 227000 | 0.085 | - |
| 1.1749 | 228000 | 0.0487 | - |
| 1.1800 | 229000 | 0.0984 | - |
| 1.1852 | 230000 | 0.0465 | - |
| 1.1903 | 231000 | 0.0492 | - |
| 1.1955 | 232000 | 0.0864 | - |
| 1.2006 | 233000 | 0.0489 | - |
| 1.2058 | 234000 | 0.0855 | - |
| 1.2109 | 235000 | 0.0579 | - |
| 1.2161 | 236000 | 0.0455 | - |
| 1.2212 | 237000 | 0.0811 | - |
| 1.2264 | 238000 | 0.0488 | - |
| 1.2315 | 239000 | 0.0547 | - |
| 1.2367 | 240000 | 0.0691 | - |
| 1.2418 | 241000 | 0.0426 | - |
| 1.2470 | 242000 | 0.0528 | - |
| 1.2521 | 243000 | 0.0552 | - |
| 1.2573 | 244000 | 0.0607 | - |
| 1.2625 | 245000 | 0.0421 | - |
| 1.2676 | 246000 | 0.0434 | - |
| 1.2728 | 247000 | 0.0632 | - |
| 1.2779 | 248000 | 0.0546 | - |
| 1.2831 | 249000 | 0.0375 | - |
| 1.2882 | 250000 | 0.038 | - |
| 1.2934 | 251000 | 0.0471 | - |
| 1.2985 | 252000 | 0.0441 | - |
| 1.3037 | 253000 | 0.0383 | - |
| 1.3088 | 254000 | 0.0521 | - |
| 1.3140 | 255000 | 0.033 | - |
| 1.3191 | 256000 | 0.0339 | - |
| 1.3243 | 257000 | 0.0363 | - |
| 1.3294 | 258000 | 0.0429 | - |
| 1.3346 | 259000 | 0.0523 | - |
| 1.3397 | 260000 | 0.0353 | - |
| 1.3449 | 261000 | 0.0271 | - |
| 1.3500 | 262000 | 0.0364 | - |
| 1.3552 | 263000 | 0.0477 | - |
| 1.3604 | 264000 | 0.0532 | - |
| 1.3655 | 265000 | 0.0595 | - |
| 1.3707 | 266000 | 0.0237 | - |
| 1.3758 | 267000 | 0.0239 | - |
| 1.3810 | 268000 | 0.0389 | - |
| 1.3861 | 269000 | 0.0288 | - |
| 1.3913 | 270000 | 0.0728 | - |
| 1.3964 | 271000 | 0.0365 | - |
| 1.4016 | 272000 | 0.038 | - |
| 1.4067 | 273000 | 0.0285 | - |
| 1.4119 | 274000 | 0.0246 | - |
| 1.4170 | 275000 | 0.0692 | - |
| 1.4222 | 276000 | 0.0281 | - |
| 1.4273 | 277000 | 0.0322 | - |
| 1.4325 | 278000 | 0.0451 | - |
| 1.4376 | 279000 | 0.0202 | - |
| 1.4428 | 280000 | 0.0274 | - |
| 1.4480 | 281000 | 0.0254 | - |
| 1.4531 | 282000 | 0.0539 | - |
| 1.4583 | 283000 | 0.0407 | - |
| 1.4634 | 284000 | 0.0286 | - |
| 1.4686 | 285000 | 0.0241 | - |
| 1.4737 | 286000 | 0.029 | - |
| 1.4789 | 287000 | 0.0337 | - |
| 1.4840 | 288000 | 0.0317 | - |
| 1.4892 | 289000 | 0.0406 | - |
| 1.4943 | 290000 | 0.0377 | - |
| 1.4995 | 291000 | 0.0238 | - |
| 1.5046 | 292000 | 0.0226 | - |
| 1.5098 | 293000 | 0.0233 | - |
| 1.5149 | 294000 | 0.0186 | - |
| 1.5201 | 295000 | 0.0255 | - |
| 1.5252 | 296000 | 0.0305 | - |
| 1.5304 | 297000 | 0.0154 | - |
| 1.5356 | 298000 | 0.0214 | - |
| 1.5407 | 299000 | 0.0187 | - |
| 1.5459 | 300000 | 0.0143 | - |
| 1.5510 | 301000 | 0.03 | - |
| 1.5562 | 302000 | 0.0346 | - |
| 1.5613 | 303000 | 0.0209 | - |
| 1.5665 | 304000 | 0.0206 | - |
| 1.5716 | 305000 | 0.0239 | - |
| 1.5768 | 306000 | 0.0262 | - |
| 1.5819 | 307000 | 0.0179 | - |
| 1.5871 | 308000 | 0.0198 | - |
| 1.5922 | 309000 | 0.0288 | - |
| 1.5974 | 310000 | 0.0192 | - |
| 1.6025 | 311000 | 0.0435 | - |
| 1.6077 | 312000 | 0.0251 | - |
| 1.6128 | 313000 | 0.0205 | - |
| 1.6180 | 314000 | 0.0246 | - |
| 1.6232 | 315000 | 0.0176 | - |
| 1.6283 | 316000 | 0.026 | - |
| 1.6335 | 317000 | 0.025 | - |
| 1.6386 | 318000 | 0.029 | - |
| 1.6438 | 319000 | 0.0274 | - |
| 1.6489 | 320000 | 0.0343 | - |
| 1.6541 | 321000 | 0.028 | - |
| 1.6592 | 322000 | 0.0282 | - |
| 1.6644 | 323000 | 0.0239 | - |
| 1.6695 | 324000 | 0.017 | - |
| 1.6747 | 325000 | 0.0132 | - |
| 1.6798 | 326000 | 0.0252 | - |
| 1.6850 | 327000 | 0.0243 | - |
| 1.6901 | 328000 | 0.0232 | - |
| 1.6953 | 329000 | 0.0183 | - |
| 1.7004 | 330000 | 0.0244 | - |
| 1.7056 | 331000 | 0.0239 | - |
| 1.7107 | 332000 | 0.0277 | - |
| 1.7159 | 333000 | 0.0223 | - |
| 1.7211 | 334000 | 0.0252 | - |
| 1.7262 | 335000 | 0.0302 | - |
| 1.7314 | 336000 | 0.0224 | - |
| 1.7365 | 337000 | 0.0188 | - |
| 1.7417 | 338000 | 0.0174 | - |
| 1.7468 | 339000 | 0.0189 | - |
| 1.7520 | 340000 | 0.0152 | - |
| 1.7571 | 341000 | 0.0185 | - |
| 1.7623 | 342000 | 0.024 | - |
| 1.7674 | 343000 | 0.0249 | - |
| 1.7726 | 344000 | 0.0202 | - |
| 1.7777 | 345000 | 0.0248 | - |
| 1.7829 | 346000 | 0.0256 | - |
| 1.7880 | 347000 | 0.022 | - |
| 1.7932 | 348000 | 0.0271 | - |
| 1.7983 | 349000 | 0.024 | - |
| 1.8035 | 350000 | 0.0241 | - |
| 1.8087 | 351000 | 0.0243 | - |
| 1.8138 | 352000 | 0.018 | - |
| 1.8190 | 353000 | 0.0236 | - |
| 1.8241 | 354000 | 0.0237 | - |
| 1.8293 | 355000 | 0.0175 | - |
| 1.8344 | 356000 | 0.015 | - |
| 1.8396 | 357000 | 0.0111 | - |
| 1.8447 | 358000 | 0.014 | - |
| 1.8499 | 359000 | 0.0146 | - |
| 1.8550 | 360000 | 0.0108 | - |
| 1.8602 | 361000 | 0.0157 | - |
| 1.8653 | 362000 | 0.0142 | - |
| 1.8705 | 363000 | 0.0129 | - |
| 1.8756 | 364000 | 0.0168 | - |
| 1.8808 | 365000 | 0.0155 | - |
| 1.8859 | 366000 | 0.017 | - |
| 1.8911 | 367000 | 0.0164 | - |
| 1.8963 | 368000 | 0.0156 | - |
| 1.9014 | 369000 | 0.0168 | - |
| 1.9066 | 370000 | 0.015 | - |
| 1.9117 | 371000 | 0.018 | - |
| 1.9169 | 372000 | 0.0151 | - |
| 1.9220 | 373000 | 0.0132 | - |
| 1.9272 | 374000 | 0.0117 | - |
| 1.9323 | 375000 | 0.0142 | - |
| 1.9375 | 376000 | 0.0151 | - |
| 1.9426 | 377000 | 0.0142 | - |
| 1.9478 | 378000 | 0.0139 | - |
| 1.9529 | 379000 | 0.014 | - |
| 1.9581 | 380000 | 0.0141 | - |
| 1.9632 | 381000 | 0.012 | - |
| 1.9684 | 382000 | 0.0127 | - |
| 1.9735 | 383000 | 0.0131 | - |
| 1.9787 | 384000 | 0.0131 | - |
| 1.9839 | 385000 | 0.0158 | - |
| 1.9890 | 386000 | 0.0211 | - |
| 1.9942 | 387000 | 0.011 | - |
| 1.9993 | 388000 | 0.0118 | - |
| 2.0000 | 388132 | - | 0.0005 |
</details>
### Framework Versions
- Python: 3.12.2
- Sentence Transformers: 3.2.1
- Transformers: 4.44.2
- PyTorch: 2.5.0
- Accelerate: 1.0.1
- Datasets: 3.0.2
- Tokenizers: 0.19.1
## Citation
### BibTeX
#### Sentence Transformers
```bibtex
@inproceedings{reimers-2019-sentence-bert,
title = "Sentence-BERT: Sentence Embeddings using Siamese BERT-Networks",
author = "Reimers, Nils and Gurevych, Iryna",
booktitle = "Proceedings of the 2019 Conference on Empirical Methods in Natural Language Processing",
month = "11",
year = "2019",
publisher = "Association for Computational Linguistics",
url = "https://arxiv.org/abs/1908.10084",
}
```
#### MultipleNegativesRankingLoss
```bibtex
@misc{henderson2017efficient,
title={Efficient Natural Language Response Suggestion for Smart Reply},
author={Matthew Henderson and Rami Al-Rfou and Brian Strope and Yun-hsuan Sung and Laszlo Lukacs and Ruiqi Guo and Sanjiv Kumar and Balint Miklos and Ray Kurzweil},
year={2017},
eprint={1705.00652},
archivePrefix={arXiv},
primaryClass={cs.CL}
}
```
<!--
## Glossary
*Clearly define terms in order to be accessible across audiences.*
-->
<!--
## Model Card Authors
*Lists the people who create the model card, providing recognition and accountability for the detailed work that goes into its construction.*
-->
<!--
## Model Card Contact
*Provides a way for people who have updates to the Model Card, suggestions, or questions, to contact the Model Card authors.*
--> |